Connect with us

Technology

Renalytix plc Reports Financial Results for First Quarter of Fiscal Year 2025

Published

on

LONDON and NEW YORK, Nov. 20, 2024 /PRNewswire/ — Renalytix plc (LSE: RENX) (OTCQB: RNLXY), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, reports its financial results for the fiscal quarter of 2025 ended September 30, 2024.  

First Quarter Fiscal 2025 and recent highlights

Continued test ordering momentum at a large New York-based physician group practice, after test ordering and processing commenced in September 2024Cash burn to be reduced to an approximate run rate of £560,000 (approximately $725,000) or less per month by the end of fiscal year 2025Financing comprising £11.8m (approximately US$14.9 million after expenses) in commitments completed subsequent to the end of the quarterCompany believes that as of November 2024, it now has sufficient cash on the balance sheet to fund current operationsIssued first guidance on multi-year revenue generation: c. $3.2m in FY25, $8.5m in FY26 and $17.5m in FY27Accomplished life sciences industry veteran Julian Baines MBE appointed as Executive Chairman.

James McCullough, CEO of Renalytix commented: “We are pleased to have positioned Renalytix financially and commercially for what we believe will be an exciting fiscal year that represents a breakout from our development phase into a commercially focused business leveraging growth within the large and unaddressed market we serve. Following our fundraise, for which we appreciate our investors’ support, we believe the wind is now behind our back and we are excited to propel the Company’s growth while supporting better patient outcomes through adoption of our kidneyintelX.dkd test by physicians and hospital systems.”

First Quarter 2025 Financial Results

During the three months ended September 30, 2024, the Company recognized $0.52 million of revenue, compared to $0.46 million for the three months ended September 30, 2023. Cost of revenue for the three months ended September 30, 2024 and 2023, was $0.42 million and $0.50 million, respectively.

Total operating expenses for the three months ended September 30, 2024 were $4.2 million, and down over 50% from $8.8 million during the prior year period.

Within operating expenses, research and development expenses were $0.9 million for the three months ended September 30, 2024, decreasing by $1.9 million from $2.8 million for the three months ended September 30, 2023. The decrease was attributable to a decrease in external R&D projects and studies, lower compensation and related benefits and a reduction in operating expenses.

General and administrative expenses were $3.3 million for the three months ended September 30, 2024, decreasing by $2.8 million from $6.1 million for the prior year period with the decrease driven by significant cost cutting measures.

Net loss was $4.7 million for the three months ended September 30, 2024, down over 50% from a net loss of $10.1 million for the prior year period.

Cash and cash equivalents totaled $0.9 million as of September 30, 2024.

Equity financing rounds, restructuring of liabilities and reduction in expenses allow sufficient cash for at least next twelve months

During October and November 2024 the Company secured additional rounds of equity financing comprising £11.8m (approximately US$14.9 million) in commitments and concurrently restructured a number of liabilities on the balance sheet. This additional equity funding, the reduction of cash expenses related to the Company’s liabilities, and an overall reduction in General and Administrative Expenses have significantly changed the Company’s financial position relative to cash needs.  As a result, the Company believes that as of November 2024, it now has sufficient cash on the Balance Sheet to fund current operations. While the possibility exists that the Company may seek additional capital, it is not required to sustain current operations for the next twelve months.

For further information, please contact:

Renalytix plc

www.renalytix.com

James McCullough, CEO

Via Walbrook PR

Stifel (Nominated Adviser and Joint Broker)

Tel: 020 7710 7600

Nicholas Moore / Nick Harland / Ben Good

Oberon Capital (Joint Broker)

Tel: 020 3179 5300

Mike Seabrook / Nick Lovering

Walbrook PR Limited

Tel: 020 7933 8780 or renalytix@walbrookpr.com

Paul McManus / Alice Woodings

Mob: 07980 541 893 / 07407 804 654

CapComm Partners

Peter DeNardo

Tel: 415-389-6400 or investors@renalytix.com

About Renalytix
Renalytix (LSE: RENX) (OTCQB: RNLXY) is an artificial intelligence enabled in-vitro diagnostics and laboratory services company that is the global founder and leader in the field of bioprognosis™ for kidney health. In late 2023, our kidneyintelX.dkd test was recognized as the first and only FDA-authorized prognostic test to enable early-stage CKD (stages 1-3b) risk assessment for progressive decline in kidney function in T2D patients. By understanding how disease will progress, patients and clinicians can take action earlier to improve outcomes and reduce overall health system costs. For more information, visit www.renalytix.com.

Forward-Looking Statements

This announcement (including any information incorporated by reference in this announcement) and other information published by the Company contain statements about the Company that are or may be deemed to be forward looking statements. Without limitation, any statements preceded or followed by or that include the words “targets”, “plans”, “believes”, “expects”, “aims”, “intends”, “will”, “may”, “anticipates”, “estimates”, “projects” or words or terms of similar substance or the negative thereof, may be forward looking statements.

These forward-looking statements are not guarantees of future performance. Such forward-looking statements involve known and unknown risks and uncertainties that could significantly affect expected results and are based on certain key assumptions. Many factors could cause actual results to differ materially from those projected or implied in any forward-looking statements. Due to such uncertainties and risks, readers should not rely on such forward-looking statements, which speak only as of the date of this announcement. The Company disclaims any obligation or responsibility to update publicly or review any forward-looking or other statements contained in this announcement, except as required by applicable law.

The distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

RENALYTIX PLC

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited)

For the Three Months Ended
September 30,

(in thousands, except share and per share data)

2024

2023

Revenue

$

522

$

459

Cost of revenue

422

502

Gross profit (loss)

100

(43)

Operating expenses:

Research and development

921

2,787

General and administrative

3,271

6,059

Total operating expenses

4,192

8,846

Loss from operations

(4,093)

(8,889)

Foreign currency gain, net

37

289

Fair value adjustment to VericiDx investment

97

(447)

Fair value adjustment to convertible notes

(762)

(1,207)

Other (expense) income, net

(5)

100

Net loss before income taxes

(4,726)

(10,154)

Income tax expense

(2)

—

Net loss

(4,728)

(10,154)

Net loss per ordinary share—basic

$

(0.04)

$

(0.11)

Net loss per ordinary share—diluted

$

(0.04)

$

(0.11)

Weighted average ordinary shares—basic

105,697,401

94,767,841

Weighted average ordinary shares—diluted

105,697,401

94,767,841

Other comprehensive income (loss):

Changes in the fair value of the convertible notes

(125)

75

Foreign exchange translation adjustment

(461)

42

Comprehensive loss

$

(5,314)

$

(10,037)

 

RENALYTIX PLC

CONSOLIDATED BALANCE SHEETS (Unaudited)

 

(in thousands, except share and per share data)

September 30,
2024

June 30,
2024

Assets

Current assets:

Cash and cash equivalents

$

909

$

4,680

Accounts receivable, net

902

722

Prepaid expenses and other current assets

1,068

716

Total current assets

2,879

6,118

Property and equipment, net

202

216

Investment in VericiDx

776

698

Other assets, net

937

940

Total assets

$

4,794

$

7,972

Liabilities and Shareholders’ Deficit

Current liabilities:

Accounts payable

$

3,188

$

1,590

Accounts payable – related party

2,408

1,018

Accrued expenses and other current liabilities

2,162

3,354

Accrued expenses – related party

102

1,329

Current lease liability

11

45

Convertible notes-current

4,142

4,159

Total current liabilities

12,013

11,495

Convertible notes-noncurrent

4,100

4,331

Total liabilities

16,113

15,826

Commitments and contingencies

Shareholders’ deficit:

Ordinary shares, £0.0025 par value per share: 173,841,695 shares
   authorized; 165,925,513 and 154,368,191 shares issued and
   outstanding at September 30, 2024 and June 30, 2024, respectively

515

478

Additional paid-in capital

206,705

204,893

Accumulated other comprehensive loss

(2,029)

(1,443)

Accumulated deficit

(216,510)

(211,782)

Total shareholders’ deficit

(11,319)

(7,854)

Total liabilities and shareholders’ deficit

$

4,794

$

7,972

 

RENALYTIX PLC

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

For the Three Months Ended
September 30,

(in thousands)

2024

2023

Cash flows from operating activities:

Net loss

$

(4,728)

$

(10,154)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

60

127

Stock-based compensation

254

523

Fair value adjustment to VericiDx investment

(97)

447

Realized loss on sale of ordinary shares in VericiDx

42

—

Realized foreign exchange gain

(18)

—

Fair value adjustment to convertible debt, net interest paid

762

945

Non cash lease expense

—

28

Provision for credit losses

(25)

—

Changes in operating assets and liabilities:

Accounts receivable

(154)

(238)

Prepaid expenses and other current assets

(327)

(153)

Accounts payable

1,550

250

Accounts payable – related party

1,390

202

Accrued expenses and other current liabilities

(1,312)

(2,060)

Accrued expenses – related party

(1,233)

579

Net cash used in operating activities

(3,836)

(9,504)

Cash flows from investing activities:

Sale of ordinary shares in VericiDx investment

23

—

Net cash provided by investing activities

23

—

Cash flows from financing activities:

Payment of convertible notes principal

—

(1,060)

Payment of offering costs

—

(5)

Net cash used by financing activities

—

(1,065)

Effect of exchange rate changes on cash

42

(222)

Net decrease in cash and cash equivalents

(3,771)

(10,791)

Cash and cash equivalents, beginning of period

4,680

24,682

Cash and cash equivalents, end of period

$

909

$

13,891

Supplemental noncash investing and financing activities:

Noncash lease liabilities arising from obtaining right-of-use assets

$

—

$

4

Cash paid for interest on convertible debt

$

—

$

249

Issuance of shares for debt repayment

$

(1,588)

$

(1,054)

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/renalytix-plc-reports-financial-results-for-first-quarter-of-fiscal-year-2025-302310978.html

SOURCE Renalytix plc

Continue Reading

Technology

GLOBAL VOTING FOR 7 WONDERS OF FUTURE CITIES OFFICIALLY SWITCHED ON

Published

on

By

DUBAI, UAE, Oct. 31, 2026 /PRNewswire/ — New Clark City, Philippines, hosts “switch-on” ceremony as New7Wonders opens worldwide public voting on www.7wondersfc.com to choose the urban developments shaping our future.

New7Wonders today officially launched global public voting for the 7 Wonders of Future Cities, in a landmark ceremony hosted in the Philippines on World Cities Day, marking the beginning of a year of worldwide participation, inviting people everywhere to vote for the cities and urban developments they believe best represent the future of urban life, which will culminate with the official declaration of the seven winning cities and developments on 31 October 2027. 

Hosted and organised by New Clark City, an Official Participant in the 7 Wonders of Future Cities campaign and one of the Philippines’ flagship urban development projects, the special switch-on ceremony brought together city leaders, media and invited guests to witness the activation of the global voting platform. 

Jean-Paul de la Fuente, Director of New7Wonders and Chairman of the 7 Wonders of Future Cities campaign, led the official switch-on. In a ceremonial moment, the campaign website at www.7wondersfc.com was transformed from its presentation format into the worldwide public voting platform, opening the opportunity for citizens across the globe to participate in selecting the urban visions that will define the cities of tomorrow. “Today, from the Philippines to the world, we have switched on more than a voting platform – we have switched on a global conversation about the future of our cities,” said de la Fuente. “For the next year, people everywhere have the opportunity to discover, engage with and champion the places they believe should become global symbols of urban progress.”

The 7 Wonders of Future Cities is a worldwide participation campaign from New7Wonders, the global authority behind the New 7 Wonders of the World and the New 7 Wonders of Nature, and is organised by Global Platform Limited, its Dubai, UAE-based worldwide licensing and commercial arm. Building on the extraordinary worldwide engagement of previous campaigns, which together have generated more than 600 million votes, the new initiative shifts the focus from celebrating humanity’s natural and historical wonders to recognising the places being created and transformed for humanity’s future. Participating cities and developments are brought together through three central themes: Environmental & Nature, Smart City and Human-Centric development. These reflect the conviction that successful future cities must balance ecological responsibility, technological progress and the needs and aspirations of the people who inhabit them.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/global-voting-for-7-wonders-of-future-cities-officially-switched-on-302925559.html

Continue Reading

Technology

SCANOLOGY Introduces AirGO Pad for On-Site 3D Scanning, Inspection and Reporting

Published

on

By

HANGZHOU, China, Oct. 31, 2026 /PRNewswire/ — SCANOLOGY introduces AirGO Pad, an integrated mobile measurement platform that brings 3D scanning, inspection and reporting alongside the part being measured. Combining computing, industrial 3D inspection software and touchscreen operation, AirGO Pad works with compatible SCANOLOGY wireless 3D scanners to help operators complete the inspection workflow on-site without carrying a separate laptop.

When inspecting a large component, operators need to move around the part while keeping scan data and measurement controls accessible. Finding a suitable place for a laptop—and returning to it to check results or adjust settings—can interrupt that process, particularly where space is limited. AirGO Pad places the inspection interface on a portable tablet, allowing operators to view data and interact with the software beside the component.

Users can connect a compatible wireless 3D scanner and view 3D data in real time, monitoring scan coverage and quality as they work. They can then align data, perform measurements and inspect results on the same device. During scanning, operators can create comparison points, features and other inspection elements as needed. Preconfigured report templates complete the workflow, enabling standardized inspection reports to be generated directly on AirGO Pad.

The platform’s design supports these transitions between scanning, inspection and reporting. Its high-definition touchscreen keeps model details and measurement results within reach. Operators can use the tablet in handheld mode while moving around the part, then unfold the convertible stand to review results on a suitable surface. A neck strap provides additional support when carrying and operating the device.

“Making a measurement system mobile means considering more than how operators carry the 3D scanner. They also need access to their data and inspection tools beside the part. We developed AirGO Pad to bring these activities together, from reviewing scan data to producing the inspection report,” said a product manager at SCANOLOGY.

AirGO Pad supports SCANOLOGY’s third-generation handheld and wireless optical 3D scanning systems, standard CAD/3D formats and wireless PC synchronization for measurement, annotation and review.

For product details or to request a demonstration, visit AirGo Pad product page.

About SCANOLOGY

SCANOLOGY develops industrial 3D measurement solutions for manufacturing and engineering. Its products are used for 3D measurement, automated inspection, and quality control. They are trusted by more than 10,000 enterprises across over 70 countries and regions, serving industries such as aerospace, automotive, and heavy manufacturing.

SOURCE SCANOLOGY

Continue Reading

Technology

SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand

Published

on

By

SHENZHEN, China, Oct. 31, 2026 /PRNewswire/ — SKYWORTH Solar has officially announced the global launch of Solavita, its dedicated brand for smart microgrid solutions. Positioned strategically as “A Smart Microgrid Expert for Diverse Energy Scenarios,” Solavita consolidates the company’s extensive solution portfolio and service infrastructure under a unified global identity, building upon its rapidly expanding international footprint.

Addressing Grid Flexibility and Long-Term System Value

The launch comes as electricity systems face growing demands for flexibility. The International Energy Agency’s 2026 mid-year electricity update highlights the importance of flexible resources and more efficient use of infrastructure as renewable generation expands. For customers, the priorities vary by market: managing electricity costs, using more locally generated solar power, or maintaining essential loads where grid supply is unreliable.

“As renewable energy becomes more distributed, the long-term performance of the whole system becomes increasingly important,” said Fan Ruiwu, Chairman of SKYWORTH Solar. “We see that performance as the foundation of our international energy business. With Solavita, we are bringing our capabilities together around a common approach to solution development and service, while working with local partners to adapt delivery to each market. Our focus is on the value these systems provide throughout their life.”

Solutions for Different Energy Needs

To address the dual challenges of grid volatility and operational cost, Solavita engineers its systems around a core architectural philosophy prioritizing grid-forming stability, intelligent automation, cross-generation efficiency, and multi-tier security. Translating these technical principles into practical applications, the brand introduces a comprehensive solution matrix tailored to specific market demands.

For residential users, the SolaHome suite utilizes an advanced Home Energy Management System (HEMS) to seamlessly coordinate rooftop solar, battery storage, and flexible domestic loads like heat pumps and EV chargers. In markets with dynamic electricity tariffs, such as Germany, HEMS automates energy dispatch to capitalize on low-price periods. This practical value is evidenced by a recent residential installation in Jesteburg, Germany, combines 18.9 kW of rooftop solar with 20.48 kWh of battery storage. Solavita reports nearly €50 in electricity-price arbitrage benefits during the first month of dynamic-tariff operation.

Expanding beyond the home, the portfolio scales up with SolaBiz, which integrates distributed solar, commercial storage, and smart dispatch to help factories and retail spaces manage peak-demand costs and safeguard against grid disruptions.

For larger utility and off-grid demands, SolaMatrix delivers scalable, containerized storage and microgrid management focused on stabilizing renewable integration in weak grid environments.

Finally, ensuring energy access in highly mobile contexts, SolaGo offers plug-and-play balcony solar and portable power systems for outdoor activities and critical emergency backup, completing Solavita’s end-to-end coverage of modern energy applications.

Global Engineering Foundation and Ecosystem Delivery

To guarantee the reliable implementation and long-term asset value of these diverse solutions, SKYWORTH Solar underpins Solavita with a robust global engineering foundation.

On the technology front, the Smart Microgrid Technology Centre connects cutting-edge research with product engineering, supported by academic collaborations with Tianjin University and Hainan University. This pipeline is further strengthened by a comprehensive Haikou test platform—scheduled for commissioning by the end of 2026—to rigorously validate grid-connected, islanded, and grid-forming systems.

The InfraCosmos Digital Platform supports lifecycle data management, operational monitoring and fault identification. It connects system information with service and maintenance, helping teams monitor performance and respond to operating issues.

Beyond hardware and software, this foundation extends to flexible supply chain execution and strategic project delivery. Solavita employs F+D+EPC+O (Financing, Development, Engineering, Procurement, Construction, and Operations) framework for large-scale, asset-light project coordination, alongside a localized PD2C cooperation model actively deployed in markets like Germany and Italy to ensure rapid, market-specific service.

These capabilities underpin Solavita’s positioning as a smart microgrid expert, connecting system development with local delivery and ongoing service. The aim is to make integrated energy systems practical to deploy and support in each market.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/skyworth-solar-announces-global-launch-of-solavita-as-a-smart-microgrid-brand-302925531.html

SOURCE SKYWORTH Solar

Continue Reading

Trending